Breast cancer has now become the most common malignancy in women globally.Chemotherapy-induced peripheral neuropathy(CIPN)is one of the common adverse reactions in chemotherapy for breast cancer,and when severe,it can significantly impact the treatment outcomes and quality of life of patients.This article provides an overview of the incidence,influencing factors,assessment tools,and intervention strategies for CIPN in breast cancer patients,with the aim of offering a reference for healthcare professionals to enhance symptom management in breast cancer patients.
维普
万方数据